TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

Medicis Pharmaceutical Corp (NYSE:MRX) Investor Investigation Over Potential Breaches Of Fiduciary Duties In Connection With The Proposed Takeover by Valeant Pharmaceuticals International

  • If you purchased shares of the Medicis Pharmaceutical Corp (NYSE:MRX) prior to August 31, 2012, and currently hold any of those NYSE:MRX shares, you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please use this form. You may also send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Investigation Overview

Sept. 3, 2012 (Shareholders Foundation) -- An investigation on behalf of investors in Medicis Pharmaceutical Corp (NYSE:MRX) shares was announced concerning whether the offer by Valeant Pharmaceuticals International to acquire Medicis Pharmaceutical Corp for $44.00 per NYSE:MRX share and the takeover process are unfair to investors in Medicis Pharmaceutical shares. The investigation...



You must register (for free) or login to view the entire investigation.

Click here to Sign In or Register (for a free account)

@screen width:
@theme:
@breakpoints:
@layout: